Work

A phase I trial of intravenously-administered recombinant tumor necrosis factor-alpha in cancer patients.

Year: 1988

Type: article

Study design: Clinical Trial

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.1988.6.8.1328

Authors: B Feinberg, R Kurzrock, M Talpaz, M Blick, S Saks, J U Gutterman

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1919752579

FWCI: 4.85

Cites: 15

Cited by: 221

Related to: 10